2 results match your criteria: "A Schweitzer Hospital[Affiliation]"
A Decade of Experience With Alemtuzumab Therapy for Severe or Glucocorticoid-Resistant Kidney Transplant Rejection.
Transpl Int
December 2023
Erasmus MC Transplant Institute, Rotterdam, Netherlands.
Alemtuzumab is used as lymphocyte-depleting therapy for severe or glucocorticoid-resistant kidney transplant rejection. However, the long-term efficacy and toxicity of alemtuzumab therapy are unclear. Therefore, all cases of alemtuzumab anti-rejection therapy between 2012 and 2022 in our institution were investigated.
View Article and Find Full Text PDFFalse-positive hepatitis B test results after intravenous immunoglobulin therapy.
Clin Kidney J
June 2019
Department of Internal Medicine, A Schweitzer Hospital, Dordrecht, The Netherlands.